ClinicalTrials.gg
RecruitingNCT06497881Updated Oct 3, 2025

Upper Limb Movement Quality Following Stroke

An observational study in Stroke, sponsored by Adi Negev-Nahalat Eran. Recruiting at 1 site in Israel. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-03.

Sponsored by Adi Negev-Nahalat Eran · Observational

How we know

From the registry’s dates

  • Started Jul 2024; still recruiting 2 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
40
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 127 studies in Stroke with a site in Israel — 12 open to participants now, 21 under way, 3 of them phase 3. Stroke · Israel.

Planned enrollment
26th of 36
40 · median 196
Started
2024
with 3 others
Observational
38 of 127
3 open now
Primary completion
2027-01
later than 10 of 20 live
Registered
118th of 127
by date
Lead sponsor
3 of 127
Adi Negev-Nahalat Eran

Among the 127 studies in Stroke with a site in Israel, this one is the 26th largest by planned enrollment of the 36 observational ones that give a count, is one of 4 that started in 2024, is one of 38 observational ones, reaches primary completion later than 10 of the 20 other live ones, and was the 118th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

12 of the 127 studies in Stroke with a site in Israel are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 127 studies in Stroke with a site in Israel, or all of them as a file.
02

Study summary

The aim of this study is to monitor the daily upper limb movement of persons with stroke, and to relate these quantities to measures of recovery and impairment.

Read the detailed description

This study is part of The Natural History of Stroke Recovery project. In this study the investigators plan to develop, test and validate an algorithm and software for using Inertial Measuring Units (IMUs) to monitor upper limb daily movement. Then, investigators plan to use this system to monitor such activity in stroke patients.

Investigators also plan to develop, test and validate an algorithm and software to test proprioception acuity based on muscle synergy during active and passive movement. Muscle synergy will be determined based on muscles' electrical activity, as measured using surface electromyography (EMG).

Investigators will then test the relation between daily movements of the upper limb in stroke patients, and their recovery/impairment levels, including proprioception acuity.

03

Conditions studied

  • Stroke

Browse trials for

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Persons with stroke and healthy adults.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • >18 years of age
  • Independent in all activities of daily living before the stroke.
  • In- and out-patients at Adi-Negev Nahalat-Eran rehabilitation center.
  • Medically stable
  • Able to provide .

Exclusion criteria

Exclusion Criteria:

  • The presence of any degenerative neurological condition, neuropathy, myopathy or Polio that are not secondary to stroke, excluding diabetic related changes.
  • Traumatic brain injury and/or extra-cerebral hemorrhage.
  • Significant psychiatric condition, including alcoholism and drug abuse.
  • Any severe orthopedic condition (such as amputation or severe pain that limits activity) or chronic pain syndrome.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Stroke

    Persons after a stroke. See inclusion/exclusion.

  • Controls

    Healthy persons. See inclusion/exclusion.

06

What researchers measure

Primary outcomes

  1. Hand movements-count

    The number of hand movements (count)

    Time frame: One or two occasions over 1-6 hours each.

  2. Hand movements-duration

    The total and average (per hour) time the hands moved, over the tested period. Measured in minutes.

    Time frame: One or two occasions over 1-6 hours each.

  3. Active joint range

    Maximum, minimum, and mean range of motion of the joints during daily activity. Measured in degrees/radians.

    Time frame: One or two occasions over 1-6 hours each.

  4. Wrist distance

    The maximum, average and total distance of the wrist from the body during movements. Measured in cm.

    Time frame: One or two occasions over 1-6 hours each.

Secondary outcomes

  1. Fugl-Meyer Assessment (FMA)

    Fugl-Meyer Assessment: Motor score of the upper limb is on a 0-66 scale. High score is better.

    Time frame: One occasions during the first month following recruitment.

  2. Action Research Arm Test (ARAT)

    Action Research Arm Test Score is on a 0-57 scale. High score is better.

    Time frame: One occasions during the first month following recruitment.

  3. Proprioception-1

    The difference between joint angles in an angle matching task. E.g., matching the shoulder angle of a passively moved arm with the contralateral arm. Angles include both anatomical angles and elevation angles. Measured in degrees/radians.

    Time frame: One occasions during the first month following recruitment.

  4. Proprioception-2

    Parameters of the correlation (regression) between EMG signals during active and passive movement. Including the constant (in mV), slope (arbitrary units) and R\^2 (arbitrary units).

    Time frame: One occasions during the first month following recruitment.

  5. Proprioception-3

    Delay between hand movement initiation observed kinematical (acceleration) and kinetically (EMG signal). Measured in msec.

    Time frame: One occasions during the first month following recruitment.

  6. Joint range of motion

    Maximum and minimum joints range of motion (active and passive). Measured in degrees/radians.

    Time frame: One or two occasions over 1-6 hours each.

  7. Synergies

    Parameters of the correlation (regression) between the kinematic signals of the different upper extremity segments. Including the slope (arbitrary units) and R\^2 (arbitrary units).

    Time frame: One or two occasions over 1-6 hours each.

  8. Angular velocity.

    Maximum and average angular velocity of the joints during daily activity. Measured in degrees/radians per second

    Time frame: One or two occasions over 1-6 hours each.

  9. Movement volume

    Volume occupied by the limb segments calculated using the 3D location of the joints. Measured in cm\^3.

    Time frame: One or two occasions over 1-6 hours each.

  10. Whole body movement time

    The total and average (per hour) time of movements of the whole body. Measured in minutes.

    Time frame: One or two occasions over 1-6 hours each.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All IPD that underlie results in a publication.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code

Time frame: Will be available with publication of results, indefinitely.

Access criteria: Open access.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2024 (actual). Primary completion is estimated for Jan 2027, 29 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2024
First posted
Jul 12, 2024
StartActual
Jul 4, 2024
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jan 1, 2027
Last update
Oct 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06497881
Lead sponsor
Adi Negev-Nahalat Eran
Collaborators
Ben-Gurion University of the Negev
Responsible party
Sponsor
First posted
Jul 12, 2024
Start date
Jul 4, 2024
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Oct 3, 2025

Study contacts

Lior Smuelof, PhD
Contact
shmuelof@gmail.com
972547510795
Yogev Koren, PhD
Contact
yogevk@post.bgu.ac.il
Lior Smuelof, PhD
principal investigator · Ben-Gurion University of the Negev
Yogev Koren, PhD
principal investigator · Ben-Gurion University of the Negev

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion